Amrize Ltd $AMRZ Stock Sold by Bryn Mawr Trust Advisors LLC

Key Points

• Bryn Mawr Trust Advisors cut its Amrize stake by 48.7% in the third quarter, selling 75,714 shares and retaining 79,640 shares valued at about $2.98 million.
• Institutional activity was mixed: several investors increased or opened positions, while Amrize directors and CEO also bought shares. The company reported quarterly EPS of $1.05, matching analysts’ estimates, with revenue up 2.6% year over year.
• Analyst views are divided, with the consensus rating at Hold and an average price target of $47.65. Amrize also declared a dividend of $0.11 per share.

Bryn Mawr Trust Advisors LLC decreased its stake in Amrize Ltd (NYSE:AMRZ - Free Report) by 48.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 79,640 shares of the company's stock after selling 75,714 shares during the period. Bryn Mawr Trust Advisors LLC's holdings in Amrize were worth $2,978,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of AMRZ. Pictet Asset Management Holding SA raised its position in shares of Amrize by 4.3% during the third quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company's stock valued at $230,110,000 after buying an additional 253,512 shares during the last quarter. CenterBook Partners LP increased its position in shares of Amrize by 1,123.6% during the 3rd quarter. CenterBook Partners LP now owns 101,408 shares of the company's stock worth $3,792,000 after purchasing an additional 93,120 shares in the last quarter. Kestra Advisory Services LLC raised its stake in shares of Amrize by 12.7% in the third quarter. Kestra Advisory Services LLC now owns 165,401 shares of the company's stock valued at $6,184,000 after acquiring an additional 18,637 shares during the last quarter. Rakuten Investment Management Inc. acquired a new position in shares of Amrize in the 3rd quarter worth approximately $1,220,000. Finally, Bank Julius Baer & Co. Ltd Zurich grew its position in Amrize by 8.8% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 2,102,975 shares of the company's stock worth $78,985,000 after acquiring an additional 170,551 shares during the last quarter.

Amrize Trading Up 2.7%

AMRZ stock opened at $42.98 on Tuesday. The company has a quick ratio of 0.67, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. Amrize Ltd has a twelve month low of $35.78 and a twelve month high of $65.94. The company has a market cap of $23.77 billion, a P/E ratio of 19.45, a PEG ratio of 1.73 and a beta of 0.04. The business has a fifty day moving average of $39.49 and a 200-day moving average of $50.25.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting analysts' consensus estimates of $1.05. The firm had revenue of $3.77 billion during the quarter. Amrize had a return on equity of 10.02% and a net margin of 9.93%. Amrize's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.98 earnings per share. As a group, equities research analysts expect that Amrize Ltd will post 2.30 EPS for the current year.

Amrize Announces Dividend

The firm also recently declared a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be given a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 10th. Amrize's payout ratio is currently 4.98%.

Insider Buying and Selling

In other Amrize news, Director Jacques Sanche purchased 4,150 shares of the company's stock in a transaction that occurred on Wednesday, August 26th. The stock was acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the completion of the purchase, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. This represents a 73.90% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jan Jenisch acquired 4,000 shares of the business's stock in a transaction that occurred on Wednesday, September 2nd. The stock was acquired at an average price of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the acquisition, the chief executive officer directly owned 519,000 shares of the company's stock, valued at $22,057,500. This trade represents a 0.78% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders have purchased 34,155 shares of company stock valued at $1,461,276. 0.54% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on Amrize from $64.00 to $56.00 and set a "buy" rating on the stock in a research note on Wednesday, September 23rd. Wall Street Zen cut Amrize from a "hold" rating to a "sell" rating in a report on Saturday. Berenberg Bank downgraded shares of Amrize from a "buy" rating to a "hold" rating and reduced their price target for the stock from $48.00 to $46.00 in a research report on Monday. Barclays decreased their price objective on shares of Amrize from $55.00 to $40.00 and set an "equal weight" rating on the stock in a report on Monday, October 19th. Finally, Truist Financial lowered their price objective on shares of Amrize from $48.00 to $35.00 and set a "hold" rating for the company in a research report on Monday, October 5th. Eight analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $47.65.

Amrize Company Profile

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets.

The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects.

Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim's North American business.

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.